Cargando…

Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment

As we age, the homeostatic function of many systems in the body, such as the immune function declines, which in turn contributes to augment susceptibility to disease. Here we describe that challenging aged mice with synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG...

Descripción completa

Detalles Bibliográficos
Autores principales: Harman, María F., Ranocchia, Romina P., Gorlino, Carolina V., Sánchez Vallecillo, María F., Castell, Sofía D., Crespo, María I., Maletto, Belkys A., Morón, Gabriel, Pistoresi-Palencia, María C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537026/
https://www.ncbi.nlm.nih.gov/pubmed/25922914
_version_ 1782385834864934912
author Harman, María F.
Ranocchia, Romina P.
Gorlino, Carolina V.
Sánchez Vallecillo, María F.
Castell, Sofía D.
Crespo, María I.
Maletto, Belkys A.
Morón, Gabriel
Pistoresi-Palencia, María C.
author_facet Harman, María F.
Ranocchia, Romina P.
Gorlino, Carolina V.
Sánchez Vallecillo, María F.
Castell, Sofía D.
Crespo, María I.
Maletto, Belkys A.
Morón, Gabriel
Pistoresi-Palencia, María C.
author_sort Harman, María F.
collection PubMed
description As we age, the homeostatic function of many systems in the body, such as the immune function declines, which in turn contributes to augment susceptibility to disease. Here we describe that challenging aged mice with synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG-ODN) emulsified in incomplete Freund's adjuvant (IFA), (CpG-ODN+IFA) an inflammatory stimulus, led to the expansion of CD11b(+)Gr1(+) myeloid cells with augmented expression of CD124 and CD31. These myeloid cells lasted longer in the spleen of aged mice than in their younger counterparts after CpG-ODN+IFA treatment and were capable of suppressing T cell proliferative response by arginase induction. Myeloid cells from aged CpG-ODN+IFA-treated mice presented increased arginase-1 expression and enzyme activity. In addition, we found a different requirement of cytokines for arginase induction according to mice age. In myeloid cells from young treated mice, arginase-1 expression and activity is induced by the presence of each IL-4 or IL-6 in their extracellular medium, unlike myeloid cells from aged treated mice which need the presence of both IL-4 and IL-6 together for arginase induction and suppressor function.
format Online
Article
Text
id pubmed-4537026
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-45370262015-08-26 Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment Harman, María F. Ranocchia, Romina P. Gorlino, Carolina V. Sánchez Vallecillo, María F. Castell, Sofía D. Crespo, María I. Maletto, Belkys A. Morón, Gabriel Pistoresi-Palencia, María C. Oncotarget Research Paper As we age, the homeostatic function of many systems in the body, such as the immune function declines, which in turn contributes to augment susceptibility to disease. Here we describe that challenging aged mice with synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG-ODN) emulsified in incomplete Freund's adjuvant (IFA), (CpG-ODN+IFA) an inflammatory stimulus, led to the expansion of CD11b(+)Gr1(+) myeloid cells with augmented expression of CD124 and CD31. These myeloid cells lasted longer in the spleen of aged mice than in their younger counterparts after CpG-ODN+IFA treatment and were capable of suppressing T cell proliferative response by arginase induction. Myeloid cells from aged CpG-ODN+IFA-treated mice presented increased arginase-1 expression and enzyme activity. In addition, we found a different requirement of cytokines for arginase induction according to mice age. In myeloid cells from young treated mice, arginase-1 expression and activity is induced by the presence of each IL-4 or IL-6 in their extracellular medium, unlike myeloid cells from aged treated mice which need the presence of both IL-4 and IL-6 together for arginase induction and suppressor function. Impact Journals LLC 2015-04-13 /pmc/articles/PMC4537026/ /pubmed/25922914 Text en Copyright: © 2015 Harman et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Harman, María F.
Ranocchia, Romina P.
Gorlino, Carolina V.
Sánchez Vallecillo, María F.
Castell, Sofía D.
Crespo, María I.
Maletto, Belkys A.
Morón, Gabriel
Pistoresi-Palencia, María C.
Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
title Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
title_full Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
title_fullStr Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
title_full_unstemmed Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
title_short Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
title_sort expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after cpg-odn plus ifa treatment
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537026/
https://www.ncbi.nlm.nih.gov/pubmed/25922914
work_keys_str_mv AT harmanmariaf expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT ranocchiarominap expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT gorlinocarolinav expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT sanchezvallecillomariaf expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT castellsofiad expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT crespomariai expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT malettobelkysa expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT morongabriel expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment
AT pistoresipalenciamariac expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment